Rubén Spretz - Publications

Affiliations: 
2001-2005 The University of Nebraska - Lincoln, Lincoln, NE 

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Capolla S, Colombo F, De Maso L, Mauro P, Bertoncin P, Kähne T, Engler A, Núñez L, Spretz R, Larsen G, Dal Bo M, Toffoli G, Macor P. Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles. Journal of Nanobiotechnology. 21: 376. PMID 37838659 DOI: 10.1186/s12951-023-02134-4  0.575
2019 Voce DJ, Bernal GM, Wu L, Crawley CD, Zhang W, Mansour NM, Cahill KE, Szymura SJ, Uppal A, Raleigh DR, Spretz R, Nunez L, Larsen G, Khodarev NN, Weichselbaum RR, et al. Temozolomide treatment induces lncRNA MALAT1 in an NF-кB and p53 co-dependent manner in glioblastoma. Cancer Research. PMID 30940658 DOI: 10.1158/0008-5472.Can-18-2170  0.56
2016 Capolla S, Mezzaroba N, Zorzet S, Tripodo C, Mendoza-Maldonado R, Granzotto M, Vita F, Spretz R, Larsen G, Noriega S, Mansilla E, Dal Bo M, Gattei V, Pozzato G, Núñez L, et al. A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles Nano Research. 9: 537-548. DOI: 10.1007/S12274-015-0935-3  0.757
2015 Capolla S, Garrovo C, Zorzet S, Lorenzon A, Rampazzo E, Spretz R, Pozzato G, Núñez L, Tripodo C, Macor P, Biffi S. Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies. International Journal of Nanomedicine. 10: 4099-109. PMID 26124662 DOI: 10.2147/Ijn.S78995  0.335
2015 Mansour NM, Bernal GM, Wu L, Crawley CD, Cahill KE, Voce DJ, Balyasnikova IV, Zhang W, Spretz R, Nunez L, Larsen GF, Weichselbaum RR, Yamini B. Decoy Receptor DcR1 Is Induced in a p50/Bcl3-Dependent Manner and Attenuates the Efficacy of Temozolomide. Cancer Research. 75: 2039-48. PMID 25808868 DOI: 10.1158/0008-5472.Can-14-2144  0.555
2015 Capolla S, Bomben R, Zorzet S, Spretz R, D'Agaro T, Larsen G, Pozzato G, Gattei V, Nunez L, Macor P. Targeted Nanoparticles for the Delivery of Antagomir17: New Approach for the Treatment of Chronic Lymphocytic Leukemia Blood. 126: 5293-5293. DOI: 10.1182/Blood.V126.23.5293.5293  0.605
2014 Bernal GM, LaRiviere MJ, Mansour N, Pytel P, Cahill KE, Voce DJ, Kang S, Spretz R, Welp U, Noriega SE, Nuñez L, Larsen G, Weichselbaum RR, Yamini B. Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 149-57. PMID 23891990 DOI: 10.1016/J.Nano.2013.07.003  0.743
2013 Mezzaroba N, Zorzet S, Secco E, Biffi S, Tripodo C, Calvaruso M, Mendoza-Maldonado R, Capolla S, Granzotto M, Spretz R, Larsen G, Noriega S, Lucafò M, Mansilla E, Garrovo C, et al. New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles. Plos One. 8: e74216. PMID 24098639 DOI: 10.1371/Journal.Pone.0074216  0.756
2011 Mansilla E, Díaz Aquino V, Zambón D, Marin GH, Mártire K, Roque G, Ichim T, Riordan NH, Patel A, Sturla F, Larsen G, Spretz R, Núñez L, Soratti C, Ibar R, et al. Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes? Stem Cells International. 2011: 943216. PMID 21716667 DOI: 10.4061/2011/943216  0.534
2011 Mansilla E, Marín G, Roque G, Díaz Aquino V, Mezzaroba N, Zorzet S, Núñez L, Larsen G, Spretz R, Noriega S, Ingrao S, Tripodo C, Tedesco F, Macor P. 5.58 Advances in the Use of Targeted Nanoparticles for the Treatment of B-CLL Clinical Lymphoma Myeloma and Leukemia. 11: S284. DOI: 10.1016/J.Clml.2011.09.212  0.751
2010 Marín GH, Mansilla E, Mezzaroba N, Zorzet S, Núñez L, Larsen G, Tau JM, Maceira A, Spretz R, Mertz C, Ingrao S, Tripodo C, Tedesco F, Macor P. Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma. Current Clinical Pharmacology. 5: 246-50. PMID 20925646 DOI: 10.2174/157488410793352058  0.607
2010 Mansilla E, Marin G, Larsen G, Roque G, Martire KE, Raimondi JC, Aquino DV, Nuñez L, Tau JM, Drago H, Sturla F, Lamonega R, Gardiner C, Spretz R, Lausada N, et al. OUTSTANDING SURVIVAL AND REGENERATION PROCESS BY THE USE OF INTELLIGENT ACELLULAR DERMAL MATRICES AND MESENCHYMAL STEM CELLS IN A BURN PIG MODEL. Transplantation Journal. 90: 467. DOI: 10.1097/00007890-201007272-00863  0.54
2004 Loscertales IG, Barrero A, Márquez M, Spretz R, Velarde-Ortiz R, Larsen G. Electrically forced coaxial nanojets for one-step hollow nanofiber design. Journal of the American Chemical Society. 126: 5376-7. PMID 15113206 DOI: 10.1021/Ja049443J  0.7
2004 Larsen G, Noriega S, Spretz R, Velarde-Ortiz R. Electrohydrodynamics and hierarchical structure control: Submicron-thick silica ribbons with an ordered hexagonal mesoporous structure Journal of Materials Chemistry. 14: 2372-2373. DOI: 10.1039/B406449F  0.661
2004 Larsen G, Spretz R, Velarde-Ortiz R. Templating of inorganic and organic solids with electrospun fibres for the synthesis of large-pore materials with near-cylindrical pores Journal of Materials Chemistry. 14: 1533-1539. DOI: 10.1039/B312453C  0.694
2004 Larsen G, Spretz R, Velarde-Ortiz R. Use of coaxial gas jackets to stabilize Taylor cones of volatile solutions and to induce particle-to-fiber transitions Advanced Materials. 16: 166-169. DOI: 10.1002/Adma.200306021  0.683
2001 Larsen G, Spretz R, Lotero E. Trapping dendrimers in inorganic matrices: DAB-Am-n/zinc arsenate composites Chemistry of Materials. 13: 4077-4082. DOI: 10.1021/Cm0103040  0.7
Show low-probability matches.